Meet Mel Mann, MBA, M.Ed - who, when diagnosed with terminal chronic myeloid leukemia (CML) in 1995, "saw a clinical trial as a chance to get tomorrow’s medicine today." Fast forward 26 years - Mel is a 26-year cancer survivor & is living proof of the life-changing power of clinical trials. He credits Dr. Druker and the life-saving drug he developed, Gleevec, for allowing him to see his daughter grow up and become a physician. At Realyze Intelligence, we harness clinician-trained-AI to empower cancer care sites to screen ALL patients for clinical trials that they may qualify for, ensuring more people like Mel can access cutting-edge treatments. We want patients to have more. More birthdays. More weddings. More graduations. More memories. More Mondays. Read more about Mel's Story https://lnkd.in/gtajzara #ClinicalTrials #CancerResearch #AIOncology #AIinPrecisionOncology #ClinicalTrialsForAll #NoMoreZombieTrials #RealyzeIntelligence
Realyze Intelligence’s Post
More Relevant Posts
-
In 2013, a study from Princess Margaret showed a 5-year survival rate of 6% for Canadians with Pancreatic Cancer. 11 years later, the rate has only risen to 10%. The slow progress is disheartening. Meanwhile, in the United States, national advocacy organization PANCAN has been proudly reporting positive trends in survival statistics each year. What changes can Canada implement to improve these numbers? Read more about this topic here: https://lnkd.in/dTwVpV3U
Diagnosis and management of pancreatic cancer
cmaj.ca
To view or add a comment, sign in
-
September is Blood Cancer Awareness Month. NbcNews #katesnow did an important story tonight on continuing FDNY FF losses from effects of dieseases linked to the 9/11 response and aftermath. However, I think they missed and important opportunity. Many of those diseases are blood cancers. Multiple myeloma is one of those. If spoken with several myeloma specialists in NYC who say the have many FDNY FFs they treat. Myeloma is is a cancer of the plasma cells in the bone marrow. Plasma cells make our antibodies and affects immune response, and has other actions that weaken bones and can lead to kidney failure (hence “multiple” in the name). While there is no cure it is treatable. Early detection is key. I was diagnosed almost 6 years ago after a high protein measure on a routine blood test. I had a good initial response (remission) and relapsed last summer. The disease is expected to have ups and downs of remission and relapse. Some relapses are king. I now a couple of folds in remission more than 20 years! Note that Rep. Steve Scalise was recently diagnosed with myeloma. If particular note is that blacks (persons of south Saharan ancestry) are more than twice as likely to develop myeloma. We don’t know why. We also don’t know the cause hazmat, diesel, benzene, and radiation exposures are expected to play a part. You can get more information at International Myeloma Foundation HealthTree Foundation and The Leukemia & Lymphoma Society I also recommend that African Americans over 30 years old check out the #PromiseStudy (promisestudy.org) wher you can be screened, followed, and referred for study. Anyone over 30 with a first degree relation (like my daughters) can also sign up. Full disclosure: I’m volunteer Coach with HealthTree, focus on providing my experience to newly diagnosed patients and those going through the stem cell (bone marrow) transplant process (technically hose dose chemotherapy and stem cell rescue!). I also help them with the CureHub system to help track their disease. #myeloma #imf #HealthTree #FDNY #NBCNews #KateSnow #stevescalise #firefighters
Home | United States | PROMISE Study: Researching Multiple Myeloma
enroll.promisestudy.org
To view or add a comment, sign in
-
Imagine receiving a fatal diagnosis. The good news, there are treatments that could potentially save your life. The bad news, you don’t have access to it. Last year, Mykella Van Cooten, a senior producer at CBC reached out to Brain Cancer Canada with a story: Canadian families affected by brain cancer who go abroad seeking potentially life-saving, non-toxic treatments, whilst paying enormous sums out of pocket. Of course, I was eager to share my family’s unique, personal story, with the hope that it would raise awareness and address the critical need for innovative brain cancer research and treatment options in Canada. I invite you, to listen to CBC’s Storylines Unapproved: the brain cancer treatment that’s not available in Canada: This is the story of Michael Cormican’s fight for brain cancer treatment, as well as my own personal thoughts on the importance of having options, quality of life, and my frustration with Health Canada | Santé Canada conservative approach towards its new drug approval process for one of the most lethal cancers we know. In Canada, brain cancer patients and their caregivers face a lack of options. By this circumstance they are pushed to become their own health advocates. They are set into a frenzy to seek treatment options beyond the current standard of care, which, is not curative and remains unchanged since 2005. In the podcast you will learn about barriers to access for Canadian brain cancer patients, notably: 1) The high costs to drug manufacturers that stand in the way of bringing treatments to Canada; 2) The heavily cumbersome process and disproportionate amount of time needed to review and authorize treatments in Canada; 3) The ensuing massive-and exceptionally inequitable- financial, emotional, and bureaucratic toll on patients and their families. Brain cancer patients and their loved ones not only value being alive, they also value life extension and quality of life. The current process by which novel treatments are made available in Canada, does not reflect the same values. Brain cancer patients in Canada deserve better!!! I am especially thankful to the Cormican family (David Cormican), and Mykella Van Cooten, for shining a light on this critical issue that affects all Canadians. https://lnkd.in/gQ3vCSRd.
Unapproved: the brain cancer treatment that's not available in Canada
cbc.ca
To view or add a comment, sign in
-
What are the urgent challenges in #BreastCancer? Professor Charlotte Coles, the Deputy Head of Cambridge's Department of Oncology, has led The Lancet Breast Cancer Commission, looking at the reasons why many people with breast cancer are being ‘systematically left behind’. Despite major advances in the diagnosis and treatment of breast cancer, inequalities mean that many women worldwide still experience significant suffering related to physical symptoms, emotional despair, and financial burden. #BreastCancer #CambridgeResearch #CambridgeUniversity #UniversityOfCambridge #Cambridge #CancerCare
Report highlights inequalities and hidden suffering among people living with breast cancer
cam.ac.uk
To view or add a comment, sign in
-
It’s tough enough to receive that diagnosis of cancer from your doctor, but how do you pay for treatment? Your medical insurance plan will not cover it all and covering the out of pocket expenses can be devastating for many patients. Here’s an interesting article from LLS that tackles the financial challenges that many cancer patients face.
Did you know? 👇 ❤️🩹 42% of cancer patients exhaust their entire life savings within two years of diagnosis. ❤️🩹 1 in 4 cancer patients delay, forgo, or dangerously alter treatment due to cost. We're dedicated to not only developing life-saving therapies but also ensuring equitable access for all. Read about our work to tackle healthcare inequities and how we’re providing crucial support to blood cancer patients in need 🔎👉 https://bit.ly/3xSDenK #HealthEquity
Improving Blood Cancer Survival Takes More than New Drug Discovery | Leukemia and Lymphoma Society
lls.org
To view or add a comment, sign in
-
Did you know? 👇 ❤️🩹 42% of cancer patients exhaust their entire life savings within two years of diagnosis. ❤️🩹 1 in 4 cancer patients delay, forgo, or dangerously alter treatment due to cost. We're dedicated to not only developing life-saving therapies but also ensuring equitable access for all. Read about our work to tackle healthcare inequities and how we’re providing crucial support to blood cancer patients in need 🔎👉 https://bit.ly/3xSDenK #HealthEquity
Improving Blood Cancer Survival Takes More than New Drug Discovery | Leukemia and Lymphoma Society
lls.org
To view or add a comment, sign in
-
What can you do today to improve equitable access to cancer care? Read this great article by Dr. Gwen Nichols!
Did you know? 👇 ❤️🩹 42% of cancer patients exhaust their entire life savings within two years of diagnosis. ❤️🩹 1 in 4 cancer patients delay, forgo, or dangerously alter treatment due to cost. We're dedicated to not only developing life-saving therapies but also ensuring equitable access for all. Read about our work to tackle healthcare inequities and how we’re providing crucial support to blood cancer patients in need 🔎👉 https://bit.ly/3xSDenK #HealthEquity
Improving Blood Cancer Survival Takes More than New Drug Discovery | Leukemia and Lymphoma Society
lls.org
To view or add a comment, sign in
-
Multiple myeloma, the 2nd most common blood cancer globally, affects both men and women with significant lifetime risks in the United States. Emerging from plasma cells in the bone marrow, this cancer disrupts the body's ability to fight infection and maintain vital functions. Recognizing the signs is key: from increased infections and fatigue to bone pain and fractures, early detection is crucial. But hope shines through advancements in treatment. From targeted therapies and immunotherapy to cutting-edge CAR-T cell therapy and bone marrow transplants, there's a range of options to combat this disease. This Multiple Myeloma Awareness Month, let's educate, advocate, and support those impacted, fostering a community of resilience and empowerment in the fight against this challenging blood cancer. #Multiplemyeloma #myeloma #bloodcancer #bonemarrow #MultipleMyelomaAwarenessMonth #MyelomaactionMonth #cancer #ZeaHealth #ZeaMed Chandra Bondugula, MD., MHI International Myeloma Foundation AACR Journals NCI Center to Reduce Cancer Health Disparities (CRCHD) Centers for Disease Control and Prevention World Health Organization Mayo Clinic American Society of Hematology WebMD MD Anderson Cancer Center Multiple Myeloma Research Foundation - MMRF New York Cancer & Blood Specialists
To view or add a comment, sign in
-
Pancreatic cancer is a challenging health issue that often goes undetected until later stages, making treatment more difficult. Known for its high fatality rates globally, symptoms usually appear after the cancer has spread. The most common type, pancreatic adenocarcinoma, is hard to catch early as it starts in a less noticeable part of the pancreas. Since the early stages usually show no symptoms, it's crucial to have regular check-ups and screenings for timely detection. Raising awareness, encouraging screenings, and working together are key to improving outcomes for pancreatic cancer. Let's unite to empower individuals, support early detection, and advance research, offering hope in the face of this challenging disease. #WorldPancreaticCancerDay #cancerawareness #cancerresearch #cancercare #pathology #immunohistochemistry #histology #tissuebaseddiagnosis #earlydiagnosis #healthcare #hospitals #oncology #fightagainstcancer #pancreaticcancerawareness #cancersurvivors Medtotes
To view or add a comment, sign in
-
Did you know that last year I was diagnosed with Neuroendocrine Cancer? Did you know that I had 5 NETs (neuroendocrine tumours) removed from my small intestine. Did you know that neuroendocrine cancer is England's 10th most prevalent cancer, and its incidence has surged by 371%, far surpassing the 116% rise in other cancers? 📈 Neuroendocrine cancer may not be as well-known, but we must spread awareness. This cancer can affect anyone because we all have a neuroendocrine system, a complex network of cells that regulates essential functions in our bodies. This remarkable system isn't just about hormones. It's also responsible for overseeing the intricate dance of our lungs, ensuring we breathe properly, and maintaining the harmony of our digestive system, helping us absorb nutrients. But, when disrupted, it can lead to neuroendocrine cancer. Early detection is critical to improving outcomes, which is why we're raising our voices today and every day. Every day is World Neuroendocrine Cancer Day for those living with this disease ❤. Thankfully my Neuroendocrine cancer was detected early and I am now Cancer free, but it's important that I keep raising awareness for all those living with NETs and all those that are yet to be diagnosed. Today is WORLD NEUROENDOCRINE CANCER DAY 🩵 Neuroendocrine Cancer UK 🌐 https://lnkd.in/ehGs5ymT #WorldNeuroendocrineCancerDay #NETCancerDay #LetsTalkAboutNETs #Neuroendocrine #NETCancer #NeuroendocrineCancer #NotJustNECancer #NeuroendocrineCancerUK #NeuroendocrineTumour #NeuroendocrineCancerAwareness Please take a moment to watch this video for World Neuroendocrine Cancer Day : https://lnkd.in/ec_pUjKs
Neuroendocrine Cancer UK - World Neuroendocrine Cancer Day 2023
https://www.youtube.com/
To view or add a comment, sign in
747 followers
Science Minded 🤖 🧠 🦾 || Patient Centered 🤍
1moI'll always advocate for #MoreMondays 💙